360 degree Tour of Disruptors

Lauren Steingold, Head of Strategy - Uber Health, Uber

@laurensteingold

A variety of studies have shown that missed patient appointments are as high as 30% nation-wide and cost the US medical system up to $150 billion annually.  Reliable transportation to appointments is a key factor in reducing no-shows.  

As Uber rolls out critically needed medical transport, many are asking, "What happens if the rider before me has an undiagnosed infectious disease using Uber to get to a medical appointment."  Today, Uber has the answers at hand.  

First, providers initiate the Uber transport and would not risk public health by using public transit for patients under observation for infectious disease.

Second, if a rider is ultimately diagnosed with an infectious disease, there are already policies in place to notify driver, alert subsequent riders, and isolate the vehicle.  In contrast, this tracking and notification would be impossible with mass transit options such as trains or buses.

Finally, Uber Health has HIPPA protections in place for riders. Overall, a compelling discussion as we consider care options such as facility-based care, home health, telemedicine, and mobile screening.  But I wonder, considering the maxed out capacity of our healthcare system today, what will be the impact of an up to 30% uptick in patient visits? How can we flex facilities to meet this demand?